Neglected Disease Research and Development: The Public Divide
The sixth G-FINDER survey reports on 2012 global investment into research and development (R&D)
of new products for neglected diseases, and identifies trends and patterns across the six years of
global G-FINDER data. It covers:
- 31 neglected diseases
- 134 product areas for these diseases, including drugs, vaccines, diagnostics, microbicides and vector control products
- Platform technologies (e.g. adjuvants, delivery technologies, diagnostic platforms)
- All types of product-related R&D, including basic research, discovery and preclinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.
In all, 201 organisations completed the survey in 2012.
Visit the Policy Cures website to learn more about the G-Finder reports.